Supporting Information
Supporting Information features previously reported antiviral activities of APD peptides (Table S1); molecular docking scores of the 104 peptides (Table S2); Ligplot+ diagrams of the hydrogen bonds and hydrophobic interactions between ACE2 and the SARS-CoV-2 RBD (Figure S1); distribution of electrostatic potential on the surface of APD peptide candidates docked to the SARS-CoV-2 RBD (Figure S2); secondary structure, docking, and distribution of electrostatic charges of aligned peptides (Figure S3); physicochemical properties, hydrogen bonds, and hydrophobic interactions of the peptide candidates against SARS-CoV-2 (Table S3); principal docking regions of screened APD and lysozyme peptides against the SARS-CoV-2 RBD (Figure S4); immunogenicity analysis of peptides against human MHC I to determine the number of alleles with IC50 < 50 nM and IC50 < 500 nM (Table S4); and the contact areas of peptides docked to SARS-CoV-2.
| Supporting Information File 1: Additional experimental data. | ||
| Format: PDF | Size: 1.5 MB | Download |
Cite the Following Article
How to Cite
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Presentation Graphic
| Picture with graphical abstract, title and authors for social media postings and presentations. | ||
| Format: PNG | Size: 9.8 MB | Download |
Citations to This Article
Scholarly Works
- Han, T.; Song, L.; Niu, X.; Qiu, M.; Wang, Y.; Wang, J.; Sun, X.; Ma, J.; Hu, S.; Feng, Z. Synergistic peptide combinations designed to suppress SARS-CoV-2. Heliyon 2024, 10, e30489. doi:10.1016/j.heliyon.2024.e30489
- Vincenzi, M.; Mercurio, F. A.; Leone, M. Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools. International journal of molecular sciences 2024, 25, 1798. doi:10.3390/ijms25031798
- Yaghoobizadeh, F.; Roayaei Ardakani, M.; Ranjbar, M. M.; Khosravi, M.; Galehdari, H. Development of a potent recombinant scFv antibody against the SARS-CoV-2 by in-depth bioinformatics study: Paving the way for vaccine/diagnostics development. Computers in biology and medicine 2024, 170, 108091. doi:10.1016/j.compbiomed.2024.108091
- Luz, A. B. S.; de Medeiros, A. F.; Bezerra, L. L.; Lima, M. S. R.; Pereira, A. S.; E Silva, E. G. O.; Passos, T. S.; Monteiro, N. d. K. V.; Morais, A. H. d. A. Prospecting native and analogous peptides with anti-SARS-CoV-2 potential derived from the trypsin inhibitor purified from tamarind seeds. Arabian journal of chemistry 2023, 16, 104886. doi:10.1016/j.arabjc.2023.104886
- Show, P.-L.; Chew, K. W.; Ong, W.-J.; Varjani, S.; Juan, J. C. New trends in nanobiotechnology. Beilstein journal of nanotechnology 2023, 14, 377–379. doi:10.3762/bjnano.14.32
